Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2022 Jan 1.

Published in final edited form as: Cancer Prev Res (Phila). 2021 May 4;14(7):697–708. doi: 10.1158/1940-6207.CAPR-20-0664

Table 2.

aCOR and 95% CI from multinomial logistic regression for non-advanced versus advanced adenomas

	Adenomatous Polyps		Sessile Serrated Polyps		Synchronous Polyps
Polyp Size	Nonadvanced Polyps <1cm	Advanced Polyps >1cm	Nonadvanced Polyps <1cm	Advanced Polyps >1cm	Nonadvanced Polyps <1cm	Advanced Polyps >1cm
N (%)	572 (88.68)	73 (11.32)	87 (86.14)	14 (13.86)	53 (75.71)	17 (24.29)
Metabolic Risk Factor	aCOR		aCOR		aCOR
BMI <25 kg/m²	ref^ǂ	ref^ǂ	ref^ǂ	ref^ǂ	ref^ǂ	ref^ǂ
BMI 25–30 kg/m²	^*1.57 (1.13, 2.20)	1.46 (0.67, 3.20)	0.83 (0.46, 1.49)	0.52 (0.13, 2.00)	1.37 (0.62, 3.05)	9.00 (0.89, 91.25)
BMI >30 kg/m²	^*1.99 (1.43, 2.77)	^*3.40 (1.64, 7.03)	1.00 (0.57, 1.77)	0.45 (0.11, 1.80)	1.44 (0.64, 3.24)	^*13.84 (1.37, 139.74)
Hypertension (yes vs no)	1.12 (0.86, 1.46)	^*2.24 (1.32, 3.79)	1.42 (0.88, 2.29)	1.44 (0.46, 4.54)	1.53 (0.84, 2.79)	^*3.83 (1.25, 11.7)
Hyperlipidemia (yes vs no)	1.05 (0.74, 1.48)	1.46 (0.78, 2.73)	1.42 (0.79, 2.56)	1.59 (0.41, 6.12)	1.24 (0.58, 2.67)	1.45 (0.44, 4.82)
Diabetes (yes vs no)	^*1.63 (1.12, 2.37)	1.43 (0.72, 2.87)	0.44 (0.15, 1.27)	1.86 (0.38, 9.11)	1.21 (0.25, 5.86)	0.81 (0.29, 2.25)

^ǂ

The reference group is the baseline group to which the other BMI categories of overweight and obese are compared to.

^*

Statistically significant findings are highlighted with an asterisk.